TrialBlood cancer journal2026

Linvoseltamab outcomes by frailty status in patients with relapsed/refractory multiple myeloma: a subgroup analysis of the LINKER-MM1 study.

Hira Mian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.